一脈陽光(02522.HK)首批數據集上架上海數據交易所
格隆匯4月2日丨一脈陽光(02522.HK)公告,2025年4月2日,公司的附屬公司北京一脈陽光醫學信息技術有限公司("北京一脈信息")"CT胸部病變標註數據"(掛牌編號:1571967301-YLIIIEJ5101)("數據集")正式通過上海數據交易所合規審覈併成功上架。
這是公司首批在上海數據交易所上架的數據集,也是繼公司構建覆蓋全國醫學影像數據生態鏈後,在醫療數據資產化領域的里程碑及突破,且標誌着公司以高質量的影像數據爲紐帶,率先打通"數據生產及治理-算法和技術-場景賦能"的閉環,使醫學影像數據要素市場化進程邁入新階段,公司也正在逐步用高質量、標準化、安全化的醫學影像數據資源爲健康中國戰略和高質量發展注入創新動能。
公司依託自主研發的"一脈雲",構建了覆蓋數據收集、數據標準、數據清洗與數據分析的全鏈條技術體系,爲數據智慧化發展打造了行業領先的數據基池。集團的"標準化編碼+精細化標註"模式爲AI模型訓練提供高質量燃料,彰顯了從數據生產到智能應用的全鏈路技術領先優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.